Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway

Arsenic is ubiquitous toxic metalloid responsible for many human diseases all over the world. Contrastingly, Ursodeoxycholic acid (UDCA) has been suggested as efficient antioxidant in various liver diseases. However, there are no reports of the effects of UDCA on arsenious acid [As(III)]-induced hep...

Full description

Bibliographic Details
Main Authors: Chao Li, Sheng Zhang, Liming Li, Qing Hu, Shen Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.594496/full
_version_ 1818429041481351168
author Chao Li
Chao Li
Sheng Zhang
Sheng Zhang
Liming Li
Qing Hu
Shen Ji
Shen Ji
author_facet Chao Li
Chao Li
Sheng Zhang
Sheng Zhang
Liming Li
Qing Hu
Shen Ji
Shen Ji
author_sort Chao Li
collection DOAJ
description Arsenic is ubiquitous toxic metalloid responsible for many human diseases all over the world. Contrastingly, Ursodeoxycholic acid (UDCA) has been suggested as efficient antioxidant in various liver diseases. However, there are no reports of the effects of UDCA on arsenious acid [As(III)]-induced hepatotoxicity. The objective of this study is to elucidate the protective actions of UDCA on As(III)-induced hepatotoxicity and explore its controlling role in biomolecular mechanisms in vivo and in vitro. The remarkable liver damage induced by As(III) was ameliorated by treatment with UDCA, as reflected by reduced histopathological changes of liver and elevation of serum AST, ALT levels. UDCA play a critical role in stabilization of cellular membrane potential, inhibition of apoptosis and LDH leakage in LO2 cells. Meanwhile, the activities of SOD, CAT and GSH-Px and the level of TSH, GSH were enhanced with UDCA administration, while the accumulations of intracellular ROS, MDA and rate of GSSG/GSH were decreased in vivo and in vitro. Further study disclosed that UDCA significantly inhibited As(III)-induced apoptosis through increasing the expression of Bcl-2 and decreasing the expression of Bax, p53, Cyt C, Cleaved caspase-3 and 9. Moreover, UDCA promoted the expression of nuclear Nrf2, HO-1, and NQO1, although arsenic regulated nuclear translocation of Nrf2 positively. When Nrf2 was silenced, the protective effect of UDCA was abolished. Collectively, the results of this study showed that UDCA protects hepatocytes antagonize As(III)-induced cytotoxicity, and its mechanism may be related to activation of Nrf2 signaling.
first_indexed 2024-12-14T15:11:13Z
format Article
id doaj.art-3053d69cc61a41faaa4a6716ca1af277
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-14T15:11:13Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-3053d69cc61a41faaa4a6716ca1af2772022-12-21T22:56:32ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-10-011110.3389/fphar.2020.594496594496Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling PathwayChao Li0Chao Li1Sheng Zhang2Sheng Zhang3Liming Li4Qing Hu5Shen Ji6Shen Ji7School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Shanghai Institute for Food and Drug Control, Shanghai, ChinaNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Shanghai Institute for Food and Drug Control, Shanghai, ChinaSchool of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin, ChinaNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Shanghai Institute for Food and Drug Control, Shanghai, ChinaNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Shanghai Institute for Food and Drug Control, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Shanghai Institute for Food and Drug Control, Shanghai, ChinaArsenic is ubiquitous toxic metalloid responsible for many human diseases all over the world. Contrastingly, Ursodeoxycholic acid (UDCA) has been suggested as efficient antioxidant in various liver diseases. However, there are no reports of the effects of UDCA on arsenious acid [As(III)]-induced hepatotoxicity. The objective of this study is to elucidate the protective actions of UDCA on As(III)-induced hepatotoxicity and explore its controlling role in biomolecular mechanisms in vivo and in vitro. The remarkable liver damage induced by As(III) was ameliorated by treatment with UDCA, as reflected by reduced histopathological changes of liver and elevation of serum AST, ALT levels. UDCA play a critical role in stabilization of cellular membrane potential, inhibition of apoptosis and LDH leakage in LO2 cells. Meanwhile, the activities of SOD, CAT and GSH-Px and the level of TSH, GSH were enhanced with UDCA administration, while the accumulations of intracellular ROS, MDA and rate of GSSG/GSH were decreased in vivo and in vitro. Further study disclosed that UDCA significantly inhibited As(III)-induced apoptosis through increasing the expression of Bcl-2 and decreasing the expression of Bax, p53, Cyt C, Cleaved caspase-3 and 9. Moreover, UDCA promoted the expression of nuclear Nrf2, HO-1, and NQO1, although arsenic regulated nuclear translocation of Nrf2 positively. When Nrf2 was silenced, the protective effect of UDCA was abolished. Collectively, the results of this study showed that UDCA protects hepatocytes antagonize As(III)-induced cytotoxicity, and its mechanism may be related to activation of Nrf2 signaling.https://www.frontiersin.org/article/10.3389/fphar.2020.594496/fullarsenicursodeoxycholic acidhepatocytesnuclear factor e2-related factor (nrf2)oxidative stressapoptosis
spellingShingle Chao Li
Chao Li
Sheng Zhang
Sheng Zhang
Liming Li
Qing Hu
Shen Ji
Shen Ji
Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
Frontiers in Pharmacology
arsenic
ursodeoxycholic acid
hepatocytes
nuclear factor e2-related factor (nrf2)
oxidative stress
apoptosis
title Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
title_full Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
title_fullStr Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
title_full_unstemmed Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
title_short Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
title_sort ursodeoxycholic acid protects against arsenic induced hepatotoxicity by the nrf2 signaling pathway
topic arsenic
ursodeoxycholic acid
hepatocytes
nuclear factor e2-related factor (nrf2)
oxidative stress
apoptosis
url https://www.frontiersin.org/article/10.3389/fphar.2020.594496/full
work_keys_str_mv AT chaoli ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT chaoli ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT shengzhang ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT shengzhang ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT limingli ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT qinghu ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT shenji ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway
AT shenji ursodeoxycholicacidprotectsagainstarsenicinducedhepatotoxicitybythenrf2signalingpathway